Avanos Medical Inc.

15.10
0.05 (0.33%)
At close: Mar 03, 2025, 3:59 PM
15.13
0.20%
After-hours: Mar 03, 2025, 04:55 PM EST

Company Description

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands.

The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy.

It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors.

The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018.

Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Avanos Medical Inc.
Avanos Medical Inc. logo
Country United States
IPO Date Oct 21, 2014
Industry Medical - Devices
Sector Healthcare
Employees 2,227
CEO Mojirade James

Contact Details

Address:
5405 Windward Parkway
Alpharetta, Georgia
United States
Website https://avanos.com

Stock Details

Ticker Symbol AVNS
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001606498
CUSIP Number 05350V106
ISIN Number US05350V1061
Employer ID 46-4987888
SIC Code 3842

Key Executives

Name Position
Warren J. Machan Interim Chief Financial Officer
John Joseph Hurley Controller
John W. Cato Vice President of Human Resources
Kerr W. Holbrook Senior Vice President & Chief Commercial Officer
Lee Burnes Senior Vice President of Global R&D, Clinical and Medical Affairs
Mojirade James Senior Vice President, General Counsel & Corporate Secretary
Scott Galovan Senior Vice President of Strategy & Corporate Development
Sigfrido Delgado Senior Vice President of Operations

Latest SEC Filings

Date Type Title
Feb 26, 2025 10-K Annual Report
Feb 26, 2025 8-K Current Report
Feb 14, 2025 SCHEDULE 13G/A [Amend] Filing
Feb 13, 2025 SCHEDULE 13G/A [Amend] Filing
Jan 13, 2025 8-K Current Report
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing
Jan 06, 2025 4 Filing